Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shirley V Wang, Ph.D.

Title
Institution
Department
Address
Phone
Fax

Overview

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01HD104646 (HUYBRECHTS, KRISTA F) Apr 12, 2021 - Mar 31, 2026
    NIH
    Active Surveillance of the Safety of Antipsychotic Medications in Pregnancy
    Role: Co-Principal Investigator
  2. R01HL141505 (WANG, SHIRLEY) Apr 1, 2019 - Mar 31, 2024
    NIH
    Randomized Cardiovascular Trials Duplicated Using Prospective Longitudinal Insurance Claims: Applying Techniques of Epidemiology (RCT DUPLICATE)
    Role: Principal Investigator
  3. R01AG053302 (WANG, SHIRLEY) Aug 1, 2018 - Apr 30, 2022
    NIH
    Understanding effectiveness of new drugs in older adults shortly after market entry
    Role: Principal Investigator
  4. R00HS022193 (WANG, SHIRLEY) Mar 1, 2015 - Feb 28, 2018
    NIH
    Methods for studying treatment heterogeneity using large observational databases
    Role: Principal Investigator
  5. K99HS022193 (WANG, SHIRLEY) Mar 5, 2013 - Feb 28, 2015
    NIH
    Methods for studying treatment heterogeneity using large observational databases
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Wang SV, Schneeweiss S. Assessing and Interpreting Real-World Evidence Studies: Introductory Points for New Reviewers. Clin Pharmacol Ther. 2021 Aug 20. PMID: 34416020.
    Citations:    Fields:    
  2. Wang SV, Maro JC, Gagne JJ, Patorno E, Kattinakere S, Stojanovic D, Eworuke E, Baro E, Ouellet-Hellstrom R, Nguyen M, Ma Y, Dashevsky I, Cole D, DeLuccia S, Hansbury A, Pestine E, Kulldorff M. A General Propensity Score for Signal Identification Using Tree-Based Scan Statistics. Am J Epidemiol. 2021 07 01; 190(7):1424-1433. PMID: 33615330.
    Citations:    Fields:    Translation:Humans
  3. Huybrechts KF, Kulldorff M, Hernández-Díaz S, Bateman BT, Zhu Y, Mogun H, Wang SV. Active Surveillance of the Safety of Medications Used During Pregnancy. Am J Epidemiol. 2021 06 01; 190(6):1159-1168. PMID: 33423046.
    Citations:    Fields:    Translation:Humans
  4. Lund LC, Hallas J, Wang SV. Online tool to create publication ready graphical depictions of longitudinal study design implemented in healthcare databases. Pharmacoepidemiol Drug Saf. 2021 Jul; 30(7):982. PMID: 33834577.
    Citations:    Fields:    
  5. Fralick M, Kulldorff M, Redelmeier D, Wang SV, Vine S, Schneeweiss S, Patorno E. A novel data mining application to detect safety signals for newly approved medications in routine care of patients with diabetes. Endocrinol Diabetes Metab. 2021 Jul; 4(3):e00237. PMID: 34277962.
    Citations:    
  6. Cadarette SM, Maclure M, Delaney JAC, Whitaker HJ, Hayes KN, Wang SV, Tadrous M, Gagne JJ, Consiglio GP, Hallas J. Control yourself: ISPE-endorsed guidance in the application of self-controlled study designs in pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2021 Jun; 30(6):671-684. PMID: 33715267.
    Citations: 1     Fields:    
  7. Wang SV, Pinheiro S, Hua W, Arlett P, Uyama Y, Berlin JA, Bartels DB, Kahler KH, Bessette LG, Schneeweiss S. STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies. BMJ. 2021 01 12; 372:m4856. PMID: 33436424.
    Citations:    Fields:    Translation:Humans
  8. Hellfritzsch M, Wang SV, Grove EL, Gagne JJ, Hallas J, Pottegård A. Using the Case-Crossover Design to Assess Short-Term Risks of Bleeding and Arterial Thromboembolism After Switching Between Oral Anticoagulants in a Population-Based Cohort of Patients With Atrial Fibrillation. Am J Epidemiol. 2020 12 01; 189(12):1467-1477. PMID: 32639512.
    Citations:    Fields:    Translation:Humans
  9. Wang SV, Stefanini K, Lewis E, Newcomer SR, Fireman B, Daley MF, Glanz JM, Duffy J, Weintraub E, Kulldorff M. Determining Which of Several Simultaneously Administered Vaccines Increase Risk of an Adverse Event. Drug Saf. 2020 10; 43(10):1057-1065. PMID: 32613596.
    Citations: 1     Fields:    Translation:Humans
  10. Orsini LS, Monz B, Mullins CD, Van Brunt D, Daniel G, Eichler HG, Graff J, Guerino J, Berger M, Lederer NM, Jonsson P, Schneeweiss S, Wang SV, Crown W, Goettsch W, Willke RJ. Improving transparency to build trust in real-world secondary data studies for hypothesis testing-Why, what, and how: recommendations and a road map from the real-world evidence transparency initiative. Pharmacoepidemiol Drug Saf. 2020 11; 29(11):1504-1513. PMID: 32924243.
    Citations:    Fields:    
  11. Orsini LS, Berger M, Crown W, Daniel G, Eichler HG, Goettsch W, Graff J, Guerino J, Jonsson P, Lederer NM, Monz B, Mullins CD, Schneeweiss S, Brunt DV, Wang SV, Willke RJ. Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative. Value Health. 2020 09; 23(9):1128-1136. PMID: 32940229.
    Citations: 2     Fields:    Translation:Humans
  12. Wang SV, Kulldorff M, Poor S, Rice DS, Banks A, Li N, Lii J, Gagne JJ. Screening Medications for Association with Progression to Wet Age-Related Macular Degeneration. Ophthalmology. 2021 02; 128(2):248-255. PMID: 32777229.
    Citations:    Fields:    Translation:Humans
  13. Bykov K, Wang SV, Hallas J, Pottegård A, Maclure M, Gagne JJ. Bias in case-crossover studies of medications due to persistent use: A simulation study. Pharmacoepidemiol Drug Saf. 2020 09; 29(9):1079-1085. PMID: 32548875.
    Citations: 2     Fields:    Translation:Humans
  14. Lee MP, Glynn RJ, Schneeweiss S, Lin KJ, Patorno E, Barberio J, Levin R, Evers T, Wang SV, Desai RJ. Risk Factors for Heart Failure with Preserved or Reduced Ejection Fraction Among Medicare Beneficiaries: Application of Competing Risks Analysis and Gradient Boosted Model. Clin Epidemiol. 2020; 12:607-616. PMID: 32606986.
    Citations: 1     
  15. Patorno E, Schneeweiss S, Wang SV. Transparency in real-world evidence (RWE) studies to build confidence for decision-making: Reporting RWE research in diabetes. Diabetes Obes Metab. 2020 04; 22 Suppl 3:45-59. PMID: 32250527.
    Citations: 2     Fields:    Translation:Humans
  16. Desai RJ, Wang SV, Vaduganathan M, Evers T, Schneeweiss S. Comparison of Machine Learning Methods With Traditional Models for Use of Administrative Claims With Electronic Medical Records to Predict Heart Failure Outcomes. JAMA Netw Open. 2020 01 03; 3(1):e1918962. PMID: 31922560.
    Citations: 32     Fields:    Translation:Humans
  17. Wyss R, Gagne JJ, Zhao Y, Zhou EH, Major JM, Wang SV, Desai RJ, Franklin JM, Schneeweiss S, Toh S, Johnson M, Fireman B. Use of Time-Dependent Propensity Scores to Adjust Hazard Ratio Estimates in Cohort Studies with Differential Depletion of Susceptibles. Epidemiology. 2020 01; 31(1):82-89. PMID: 31569120.
    Citations:    Fields:    Translation:Humans
  18. Wang SV, Patterson OV, Gagne JJ, Brown JS, Ball R, Jonsson P, Wright A, Zhou L, Goettsch W, Bate A. Transparent Reporting on Research Using Unstructured Electronic Health Record Data to Generate 'Real World' Evidence of Comparative Effectiveness and Safety. Drug Saf. 2019 11; 42(11):1297-1309. PMID: 31452075.
    Citations: 1     Fields:    Translation:Humans
  19. Dong YH, Wang SV, Gagne JJ, Wu LC, Chang CH. Comparison of Different Case-Crossover Variants in Handling Exposure-Time Trend or Persistent-User Bias: Using Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure as an Example. Value Health. 2020 02; 23(2):217-226. PMID: 32113627.
    Citations:    Fields:    Translation:Humans
  20. Straub L, Gagne JJ, Maro JC, Nguyen MD, Beaulieu N, Brown JS, Kennedy A, Johnson M, Wright A, Zhou L, Wang SV. Evaluation of Use of Technologies to Facilitate Medical Chart Review. Drug Saf. 2019 09; 42(9):1071-1080. PMID: 31111340.
    Citations: 1     Fields:    Translation:Humans
  21. Wang SV, Rogers JR, Jin Y, DeiCicchi D, Dejene S, Connors JM, Bates DW, Glynn RJ, Fischer MA. Stepped-wedge randomised trial to evaluate population health intervention designed to increase appropriate anticoagulation in patients with atrial fibrillation. BMJ Qual Saf. 2019 10; 28(10):835-842. PMID: 31243156.
    Citations: 3     Fields:    Translation:Humans
  22. Langan SM, Schmidt SAJ, Wing K, Ehrenstein V, Nicholls SG, Filion KB, Klungel O, Petersen I, Sørensen HT, Dixon WG, Guttmann A, Harron K, Hemkens LG, Moher D, Schneeweiss S, Smeeth L, Sturkenboom M, von Elm E, Wang SV, Benchimol EI. CMAJ. 2019 06 24; 191(25):E689-E708. PMID: 31235490.
    Citations: 1     Fields:    
  23. Wang SV, Li N, Rice DS, Grosskreutz CL, Dryja TP, Prasanna G, Lii J, Gagne JJ. Using Healthcare Databases to Refine Understanding of Exploratory Associations Between Drugs and Progression of Open-Angle Glaucoma. Clin Pharmacol Ther. 2019 10; 106(4):874-883. PMID: 31038730.
    Citations: 1     Fields:    Translation:Humans
  24. Ray GT, Lewis N, Klein NP, Daley MF, Wang SV, Kulldorff M, Fireman B. Intraseason Waning of Influenza Vaccine Effectiveness. Clin Infect Dis. 2019 05 02; 68(10):1623-1630. PMID: 30204855.
    Citations: 16     Fields:    Translation:HumansCellsPHPublic Health
  25. Desai RJ, Wyss R, Abdia Y, Toh S, Johnson M, Lee H, Karami S, Major JM, Nguyen M, Wang SV, Franklin JM, Gagne JJ. Evaluating the use of bootstrapping in cohort studies conducted with 1:1 propensity score matching-A plasmode simulation study. Pharmacoepidemiol Drug Saf. 2019 06; 28(6):879-886. PMID: 31020732.
    Citations:    Fields:    Translation:Humans
  26. Wang SV. Commentary in response to Carrigan et al: "An Evaluation of the Impact of Missing Deaths on Overall Survival Analyses of Advanced Non-small Cell Lung Cancer Patients Conducted in an Electronic Health Records Database". Pharmacoepidemiol Drug Saf. 2019 05; 28(5):582-583. PMID: 30873670.
    Citations:    Fields:    Translation:Humans
  27. Schneeweiss S, Rassen JA, Brown JS, Rothman KJ, Happe L, Arlett P, Dal Pan G, Goettsch W, Murk W, Wang SV. Graphical Depiction of Longitudinal Study Designs in Health Care Databases. Ann Intern Med. 2019 03 19; 170(6):398-406. PMID: 30856654.
    Citations: 16     Fields:    Translation:Humans
  28. Desai RJ, Lin KJ, Patorno E, Barberio J, Lee M, Levin R, Evers T, Wang SV, Schneeweiss S. Development and Preliminary Validation of a Medicare Claims-Based Model to Predict Left Ventricular Ejection Fraction Class in Patients With Heart Failure. Circ Cardiovasc Qual Outcomes. 2018 12; 11(12):e004700. PMID: 30562067.
    Citations: 7     Fields:    Translation:Humans
  29. Langan SM, Schmidt SA, Wing K, Ehrenstein V, Nicholls SG, Filion KB, Klungel O, Petersen I, Sorensen HT, Dixon WG, Guttmann A, Harron K, Hemkens LG, Moher D, Schneeweiss S, Smeeth L, Sturkenboom M, von Elm E, Wang SV, Benchimol EI. The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE). BMJ. 2018 Nov 14; 363:k3532. PMID: 30429167.
    Citations: 43     Fields:    Translation:Humans
  30. Desai RJ, Wyss R, Jin Y, Bohn J, Toh S, Cosgrove A, Kennedy A, Kim J, Kim C, Ouellet-Hellstrom R, Karami S, Major JM, Niman A, Wang SV, Gagne JJ. Extension of Disease Risk Score-Based Confounding Adjustments for Multiple Outcomes of Interest: An Empirical Evaluation. Am J Epidemiol. 2018 11 01; 187(11):2439-2448. PMID: 29947726.
    Citations: 3     Fields:    Translation:Humans
  31. Wang SV, Maro JC, Baro E, Izem R, Dashevsky I, Rogers JR, Nguyen M, Gagne JJ, Patorno E, Huybrechts KF, Major JM, Zhou E, Reidy M, Cosgrove A, Schneeweiss S, Kulldorff M. Data Mining for Adverse Drug Events With a Propensity Score-matched Tree-based Scan Statistic. Epidemiology. 2018 11; 29(6):895-903. PMID: 30074538.
    Citations: 4     Fields:    Translation:Humans
  32. Wang SV, Schneeweiss S, Gagne JJ, Evers T, Gerlinger C, Desai R, Najafzadeh M. Using Real-World Data to Extrapolate Evidence From Randomized Controlled Trials. Clin Pharmacol Ther. 2019 05; 105(5):1156-1163. PMID: 30107034.
    Citations: 3     Fields:    Translation:Humans
  33. Gagne JJ, Tsacogianis T, Bruce Wirta S, Rogers JR, Calado F, Chang CL, Turner SJ, Schlienger RG, Balas B, Abdurrob A, Najafzadeh M, Wang SV. Characteristics of early sacubitril/valsartan patients and considerations for studies in electronic health record data. J Comp Eff Res. 2018 11; 7(11):1073-1082. PMID: 30156128.
    Citations:    Fields:    Translation:Humans
  34. Ladha KS, Gagne JJ, Patorno E, Huybrechts KF, Rathmell JP, Wang SV, Bateman BT. Opioid Overdose After Surgical Discharge. JAMA. 2018 Aug 07; 320(5):502-504. PMID: 30087999.
    Citations: 10     Fields:    Translation:Humans
  35. Wang SV, Jin Y, Fireman B, Gruber S, He M, Wyss R, Shin H, Ma Y, Keeton S, Karami S, Major JM, Schneeweiss S, Gagne JJ. Relative Performance of Propensity Score Matching Strategies for Subgroup Analyses. Am J Epidemiol. 2018 08 01; 187(8):1799-1807. PMID: 29554199.
    Citations: 6     Fields:    Translation:Humans
  36. Pottegård A, Hallas J, Wang SV, Gagne JJ. Identifying signals of interest when screening for drug-outcome associations in health care data. Br J Clin Pharmacol. 2018 09; 84(9):1865-1867. PMID: 29862551.
    Citations: 4     Fields:    Translation:Humans
  37. Wang SV, Kulldorff M, Glynn RJ, Gagne JJ, Pottegård A, Rothman KJ, Schneeweiss S, Walker AM. Reuse of data sources to evaluate drug safety signals: When is it appropriate? Pharmacoepidemiol Drug Saf. 2018 06; 27(6):567-569. PMID: 29701279.
    Citations: 5     Fields:    Translation:Humans
  38. Hallas J, Wang SV, Gagne JJ, Schneeweiss S, Pratt N, Pottegård A. Hypothesis-free screening of large administrative databases for unsuspected drug-outcome associations. Eur J Epidemiol. 2018 Jun; 33(6):545-555. PMID: 29605890.
    Citations: 5     Fields:    
  39. Carnahan RM, Kuntz JL, Wang SV, Fuller C, Gagne JJ, Leonard CE, Hennessy S, Meyer T, Archdeacon P, Chen CY, Panozzo CA, Toh S, Katcoff H, Woodworth T, Iyer A, Axtman S, Chrischilles EA. Evaluation of the US Food and Drug Administration sentinel analysis tools in confirming previously observed drug-outcome associations: The case of clindamycin and Clostridium difficile infection. Pharmacoepidemiol Drug Saf. 2018 07; 27(7):731-739. PMID: 29532543.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  40. Najafzadeh M, Schneeweiss S, Choudhry NK, Wang SV, Gagne JJ. Simulation for Predicting Effectiveness and Safety of New Cardiovascular Drugs in Routine Care Populations. Clin Pharmacol Ther. 2018 11; 104(5):1008-1015. PMID: 29424437.
    Citations: 1     Fields:    Translation:Humans
  41. Wang SV, Abdurrob A, Spoendlin J, Lewis E, Newcomer SR, Fireman B, Daley MF, Glanz JM, Duffy J, Weintraub ES, Kulldorff M. Methods for addressing "innocent bystanders" when evaluating safety of concomitant vaccines. Pharmacoepidemiol Drug Saf. 2018 04; 27(4):405-412. PMID: 29441647.
    Citations:    Fields:    Translation:HumansPHPublic Health
  42. Wang SV, Huybrechts KF, Fischer MA, Franklin JM, Glynn RJ, Schneeweiss S, Gagne JJ. Generalized boosted modeling to identify subgroups where effect of dabigatran versus warfarin may differ: An observational cohort study of patients with atrial fibrillation. Pharmacoepidemiol Drug Saf. 2018 04; 27(4):383-390. PMID: 29383858.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  43. Zhou M, Wang SV, Leonard CE, Gagne JJ, Fuller C, Hampp C, Archdeacon P, Toh S, Iyer A, Woodworth TS, Cavagnaro E, Panozzo CA, Axtman S, Carnahan RM, Chrischilles EA, Hennessy S. Sentinel Modular Program for Propensity Score-Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious Hypoglycemia. Epidemiology. 2017 11; 28(6):838-846. PMID: 28682851.
    Citations: 12     Fields:    Translation:HumansPHPublic Health
  44. Wang SV, He M, Jin Y, Wyss R, Shin H, Ma Y, Keeton S, Fireman B, Karami S, Major JM, Schneeweiss S, Gagne JJ. A review of the performance of different methods for propensity score matched subgroup analyses and a summary of their application in peer-reviewed research studies. Pharmacoepidemiol Drug Saf. 2017 Dec; 26(12):1507-1512. PMID: 28984001.
    Citations: 4     Fields:    Translation:Humans
  45. Connolly JG, Wang SV, Fuller CC, Toh S, Panozzo CA, Cocoros N, Zhou M, Gagne JJ, Maro JC. Development and application of two semi-automated tools for targeted medical product surveillance in a distributed data network. Curr Epidemiol Rep. 2017 Dec; 4(4):298-306. PMID: 29204333.
    Citations: 3     
  46. Berger ML, Sox H, Willke RJ, Brixner DL, Eichler HG, Goettsch W, Madigan D, Makady A, Schneeweiss S, Tarricone R, Wang SV, Watkins J, Mullins CD. Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making. Value Health. 2017 09; 20(8):1003-1008. PMID: 28964430.
    Citations: 40     Fields:    Translation:Humans
  47. Wang SV, Schneeweiss S, Berger ML, Brown J, de Vries F, Douglas I, Gagne JJ, Gini R, Klungel O, Mullins CD, Nguyen MD, Rassen JA, Smeeth L, Sturkenboom M. Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0. Value Health. 2017 09; 20(8):1009-1022. PMID: 28964431.
    Citations: 9     Fields:    Translation:Humans
  48. Berger ML, Sox H, Willke RJ, Brixner DL, Eichler HG, Goettsch W, Madigan D, Makady A, Schneeweiss S, Tarricone R, Wang SV, Watkins J, Daniel Mullins C. Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making. Pharmacoepidemiol Drug Saf. 2017 Sep; 26(9):1033-1039. PMID: 28913966.
    Citations: 52     Fields:    Translation:Humans
  49. Wang SV, Schneeweiss S, Berger ML, Brown J, de Vries F, Douglas I, Gagne JJ, Gini R, Klungel O, Mullins CD, Nguyen MD, Rassen JA, Smeeth L, Sturkenboom M. Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0. Pharmacoepidemiol Drug Saf. 2017 09; 26(9):1018-1032. PMID: 28913963.
    Citations: 30     Fields:    Translation:Humans
  50. Franklin JM, Dejene S, Huybrechts KF, Wang SV, Kulldorff M, Rothman KJ. A Bias in the Evaluation of Bias Comparing Randomized Trials with Nonexperimental Studies. Epidemiol Methods. 2017 Apr; 6(1). PMID: 29204330.
    Citations: 3     
  51. Wang SV, Rogers JR, Jin Y, Bates DW, Fischer MA. Use of electronic healthcare records to identify complex patients with atrial fibrillation for targeted intervention. J Am Med Inform Assoc. 2017 Mar 01; 24(2):339-344. PMID: 27375290.
    Citations: 10     Fields:    Translation:Humans
  52. Kesselheim AS, Bykov K, Gagne JJ, Wang SV, Choudhry NK. Switching generic antiepileptic drug manufacturer not linked to seizures: A case-crossover study. Neurology. 2016 Oct 25; 87(17):1796-1801. PMID: 27683844.
    Citations: 8     Fields:    Translation:Humans
  53. Wang SV, Franklin JM, Glynn RJ, Schneeweiss S, Eddings W, Gagne JJ. Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study. BMJ. 2016 May 24; 353:i2607. PMID: 27221664.
    Citations: 12     Fields:    Translation:Humans
  54. Patorno E, Wang SV, Schneeweiss S, Liu J, Bateman BT. Initiation patterns of statin therapy among adult patients undergoing intermediate to high-risk non-cardiac surgery. Pharmacoepidemiol Drug Saf. 2016 Jan; 25(1):64-72. PMID: 26494361.
    Citations: 1     Fields:    Translation:Humans
  55. Patorno E, Wang SV, Schneeweiss S, Liu J, Bateman BT. Patterns of ß-blocker initiation in patients undergoing intermediate to high-risk noncardiac surgery. Am Heart J. 2015 Oct; 170(4):812-820.e6. PMID: 26386806.
    Citations:    Fields:    Translation:Humans
  56. Pottegård A, dePont Christensen R, Wang SV, Gagne JJ, Larsen TB, Hallas J. Pharmacoepidemiological assessment of drug interactions with vitamin K antagonists. Pharmacoepidemiol Drug Saf. 2014 Nov; 23(11):1160-7. PMID: 25250949.
    Citations: 2     Fields:    Translation:Humans
  57. Wang SV, Schneeweiss S, Rassen JA. Optimal matching ratios in drug safety surveillance. Epidemiology. 2014 Sep; 25(5):772-3. PMID: 25076153.
    Citations: 1     Fields:    Translation:Humans
  58. Wang SV, Schneeweiss S, Maclure M, Gagne JJ. "First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designs. Am J Epidemiol. 2014 Sep 15; 180(6):636-44. PMID: 25086050.
    Citations: 6     Fields:    Translation:Humans
  59. Gagne JJ, Wang SV, Rassen JA, Schneeweiss S. A modular, prospective, semi-automated drug safety monitoring system for use in a distributed data environment. Pharmacoepidemiol Drug Saf. 2014 Jun; 23(6):619-27. PMID: 24788694.
    Citations: 7     Fields:    Translation:Humans
  60. Wang SV, Gagne JJ, Glynn RJ, Schneeweiss S. Case-crossover studies of therapeutics: design approaches to addressing time-varying prognosis in elderly populations. Epidemiology. 2013 May; 24(3):375-8. PMID: 23466528.
    Citations: 7     Fields:    Translation:Humans
  61. Brunelli SM, Gagne JJ, Huybrechts KF, Wang SV, Patrick AR, Rothman KJ, Seeger JD. Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates. Pharmacoepidemiol Drug Saf. 2013 May; 22(5):542-50. PMID: 23526818.
    Citations: 27     Fields:    Translation:Humans
  62. Wang S, Linkletter C, Dore D, Mor V, Buka S, Maclure M. Age, antipsychotics, and the risk of ischemic stroke in the Veterans Health Administration. Stroke. 2012 Jan; 43(1):28-31. PMID: 22033997.
    Citations: 8     Fields:    Translation:Humans
  63. Wang S, Linkletter C, Maclure M, Dore D, Mor V, Buka S, Wellenius GA. Future cases as present controls to adjust for exposure trend bias in case-only studies. Epidemiology. 2011 Jul; 22(4):568-74. PMID: 21577117.
    Citations: 14     Fields:    Translation:Humans
  64. Wang SV, Coull BA, Schwartz J, Mittleman MA, Wellenius GA. Potential for bias in case-crossover studies with shared exposures analyzed using SAS. Am J Epidemiol. 2011 Jul 01; 174(1):118-24. PMID: 21540322.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Wang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (211)
Explore
_
Co-Authors (33)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.